Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Flurazepam hydrochloride
Drug ID BADD_D00940
Description A benzodiazepine derivative used mainly as a hypnotic.
Indications and Usage For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits
Marketing Status approved; illicit; investigational
ATC Code N05CD01
DrugBank ID DB00690
KEGG ID D00695; D01408
MeSH ID D005479
PubChem ID 14434
TTD Drug ID D08XFV
NDC Product Code 48087-0021; 12828-0017
UNII 756RDM536M
Synonyms Flurazepam | Dalmane | Dalmadorm | Dormodor | Flurazepam Hydrochloride | Hydrochloride, Flurazepam | Flurazepam Dihydrochloride | Dihydrochloride, Flurazepam | Flurazepam Monohydrochloride | Monohydrochloride, Flurazepam | Staurodorm | Apo-Flurazepam | Apo Flurazepam | Flurazepam Mono-Perchlorate | Flurazepam Mono Perchlorate | Mono-Perchlorate, Flurazepam
Chemical Information
Molecular Formula C21H23ClFN3O.2ClH
CAS Registry Number 1172-18-5
SMILES CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F.Cl.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypotension24.06.03.002--
Irritability19.04.02.013; 08.01.03.011--
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Leukopenia01.02.02.001--Not Available
Logorrhoea17.02.08.006; 19.19.02.001--Not Available
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Pain08.01.08.004--
Palpitations02.11.04.012--
Pruritus23.03.12.001--
Rash23.03.13.001--Not Available
Restlessness19.11.02.002; 17.02.05.021--
Salivary hypersecretion07.06.01.009--Not Available
Sedation17.02.04.005--Not Available
Somnolence17.02.04.006; 19.02.05.003--
Syncope02.11.04.015; 24.06.02.012; 17.02.04.008--
Vision blurred17.17.01.010; 06.02.06.007--
Vomiting07.01.07.003--
Paradoxical drug reaction08.06.01.014--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Genitourinary tract infection21.10.03.005; 20.08.02.003; 11.01.14.005--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
The 2th Page    First    Pre   2    Total 2 Pages